The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of 2
different doses of canagliflozin administered as monotherapy compared with placebo in
patients with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise.